A method for detecting a traditional Chinese medicine composition
By combining HPLC with gradient elution technology, the problems of accuracy and repeatability in the detection of components in traditional Chinese medicine compositions have been solved, enabling reliable detection of the content of components in traditional Chinese medicine compositions and supporting research on the pharmacodynamic material basis and formulation development.
Patent Information
- Application Number
- CN202510295408.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2024-03-13
- Filing Date
- 2025-03-13
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2045-03-13
AI Technical Summary
Existing technologies lack effective quality control methods for traditional Chinese medicine compositions, especially for the accurate and reproducible detection of the content of components such as Sinomenium acutum and Sophora flavescens, which affects the research on the pharmacodynamic material basis and the development of formulations.
High-performance liquid chromatography (HPLC) combined with gradient elution technology, using a C18 column and a specific mobile phase gradient elution program, was employed to detect the content of matrine, sophoridine, sinomenine, protopine, corydaline B, and corydaline A in traditional Chinese medicine compositions. Optimized chromatographic conditions ensured the specificity, repeatability, and accuracy of the detection.
It enables accurate detection of the components of traditional Chinese medicine compositions, ensuring the reliability of pharmacodynamic material basis research and the overall evaluation of preparation quality, and providing a basis for quality control.
Smart Images

Figure CN120121741B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of analytical chemistry, and in particular to a method for detecting traditional Chinese medicine compositions. Background Technology
[0002] This prescription, composed of nine herbs including *Sinomenium acutum*, *Sophora flavescens*, *Anemarrhena asphodeloides*, *Siegesbeckia orientalis*, *Corydalis yanhusuo*, *Ajuga decumbens*, *Ligusticum striatum*, *Dioscorea hypoglauca*, and *Acanthopanax senticosus*, possesses the effects of clearing the meridians and relaxing muscles, dispersing nodules and relieving pain, and dispelling wind and dampness. It is primarily used to treat recurrent episodes of arthralgia characterized by muscle spasms, difficulty in flexion and extension, and subcutaneous nodules; or acute exacerbations of arthralgia characterized by significant joint redness, swelling, heat, and pain, accompanied by fever and thirst. Pharmacological studies have shown that it has good clinical efficacy in treating active rheumatoid arthritis (RA). By regulating the inflammatory response and targeting angiogenesis in RA, it inhibits angiogenesis, thereby improving symptoms and treating rheumatic diseases. Current research is mainly focused on pharmacodynamics, with relatively weak research on the pharmacodynamic material basis.
[0003] Traditional Chinese medicine (TCM) compound formulas are complex, characterized by multiple targets and effects. They follow the principle of principal, assistant, and adjuvant drug combinations, with the principal drug playing a primary therapeutic role and the assistant drugs enhancing the treatment of the main disease. In this formula, the principal drugs, *Sinomenium acutum* and *Sophora flavescens*, are commonly used TCM herbs for treating rheumatoid arthritis and have good efficacy. Alkaloids in *Sinomenium acutum* are its main effective components for dispelling wind and relieving pain; sinomenine is its main active ingredient and also a key indicator for the quality control and evaluation of *Sinomenium acutum*. Previous research by the inventors has shown that multiple components in *Sophora flavescens*, such as matrine and sophoridine, have antitumor activity and anti-inflammatory and analgesic effects. The assistant drug, *Corydalis yanhusuo*, has alkaloids with analgesic, sedative, anti-inflammatory, and antitumor effects; and the total alkaloids of *Corydalis yanhusuo* can effectively inhibit central and peripheral pain. Therefore, this paper establishes an HPLC method for the simultaneous determination of six components: matrine, sophoridine, sinomenine, protopine, corydaline B, and corydaline A, providing a reference for the research on the pharmacodynamic material basis of the TCM composition, quality control, and subsequent formulation development. Summary of the Invention
[0004] To achieve the above-mentioned objectives, the present invention provides the following technical solution:
[0005] A method for detecting the content of a traditional Chinese medicine composition, characterized in that a test solution of the traditional Chinese medicine composition is subjected to HPLC detection, wherein the chromatographic conditions for HPLC detection include:
[0006] A C18 column (5 μm, 4.6 × 250 mm) was used; acetonitrile was used as mobile phase A, and phosphate buffer solution (pH 5.8) was used as mobile phase B. The elution in the HPLC detection was gradient elution, and the gradient elution program was as follows: 0–25 min, 5% A; 25–35 min, 5%–7% A; 35–50 min, 7%–15% A; 50–60 min, 15%–19% A; 60–80 min, 19%–20% A; 80–90 min, 20%–35% A; 90–115 min, 35% A; 115–120 min, 35%–44% A; 120–145 min, 44%–48% A.
[0007] Specifically, the traditional Chinese medicine composition includes nine herbs: *Sinomenium acutum*, *Sophora flavescens*, *Anemarrhena asphodeloides*, *Siegesbeckia orientalis*, *Corydalis yanhusuo*, *Ajuga decumbens*, *Smilax china*, and *Acanthopanax senticosus*.
[0008] Furthermore, the chromatographic conditions include: a flow rate of 0.8–1.0 mL / min, a column temperature of 25–35 °C, and a detection wavelength of 208–212 nm.
[0009] Furthermore, the chromatographic conditions include: a flow rate of 0.9 mL / min, a column temperature of 30 °C, and a detection wavelength of 210 nm.
[0010] Specifically, the C18 column is selected from Phenomenex Gemini C18 column or Phenomenex Luna C18 column.
[0011] Specifically, the traditional Chinese medicine composition can be a solid, liquid, or external preparation; for example: decoction, granules, capsules, tablets, pills, oral liquid, tincture, syrup, suppository, gel, spray, injection, etc.
[0012] Furthermore, when the traditional Chinese medicine composition is in the form of granules, its preparation method includes: 10 parts of *Sinomenium acutum*, 10 parts of *Sophora flavescens*, 15 parts of *Siegesbeckia orientalis*, 15 parts of *Corydalis yanhusuo*, 15 parts of *Ajuga decumbens*, 15 parts of *Illicium verum*, 10 parts of *Dioscorea hypoglauca*, 12 parts of *Acanthopanax senticosus*, and 10 parts of *Anemarrhena asphodeloides*, these nine medicinal materials are decocted twice with 10 times the amount of water, each time for 1.5 hours, and concentrated under reduced pressure to an extract with a relative density of 1.08-1.12 (60℃-70℃). The extract is then spray-dried, pulverized, and excipients are added. Finally, it is dry-granulated to obtain the final product.
[0013] Optionally, the test solution is prepared as follows: Take 0.64 g of the extract, accurately weigh it, place it in a stoppered conical flask, add 30 mL of purified water, sonicate for 15 minutes to dissolve (power 500 W, frequency 40 kHz), then transfer it to a separatory funnel, add chloroform to extract 5 times, 30 mL each time, combine the chloroform layers, evaporate to dryness, dissolve the residue in methanol, and dilute to a 10 mL volumetric flask to obtain the test solution.
[0014] Optionally, the test solution is prepared as follows: 0.3 g of the product granules are accurately weighed and placed in a stoppered conical flask. 30 mL of purified water is added, and the solution is sonicated for 15 minutes to dissolve it (power 500 W, frequency 40 kHz). Then, the solution is transferred to a separatory funnel, and 30 mL of chloroform is added for extraction 5 times. The chloroform layers are combined, evaporated to dryness, and the residue is dissolved in methanol and diluted to a 10 mL volumetric flask to obtain the final solution.
[0015] Furthermore, the above detection method also includes the detection of reference standards, which include one or more of matrine, sophoridine, sinomenine, protopine, corydaline B, and corydaline A standards.
[0016] Specifically, the method for preparing the reference standard into a solution for detection is as follows: Take matrine, sophoridine, sinomenine, protopine, corydaline B, and corydaline A standards, add methanol to prepare a single or mixed standard solution containing 7.98–319.37 μg of matrine, 3.21–320.75 μg of sophoridine, 9.15–366.03 μg of sinomenine, 0.27–27.44 μg of protopine, 0.47–46.96 μg of corydaline B, and 0.42–42.00 μg of corydaline A per 1 mL.
[0017] By establishing a standard curve for one or more reference standards, information on the composition or content of the components can be obtained.
[0018] This invention provides a method for detecting the content of components in a composition comprising *Sinomenium acutum*, *Sophora flavescens*, *Anemarrhena asphodeloides*, *Siegesbeckia orientalis*, *Corydalis yanhusuo*, *Ajuga decumbens*, *Ligusticum striatum*, *Dioscorea hypoglauca*, and *Acanthopanax senticosus*. Systematic methodological investigation and verification show that this method has strong specificity, good robustness, repeatability, and accuracy. Using this method to detect the chemical components or their content in the composition, a method for determining the content of granules can be established, comprehensively reflecting its quality and providing an overall description and evaluation of the preparation's quality. Attached Figure Description
[0019] Figure 1 Spectrograms of different mobile phases for detecting the content of components in traditional Chinese medicine compositions;
[0020] Figure 2 Chromatograms were examined using a gradient elution procedure for the determination of component content in traditional Chinese medicine compositions.
[0021] Figure 3 Chromatogram for specificity investigation of component content detection of traditional Chinese medicine composition. Wherein, 1 - matrine; 2 - sophocarpine; 3 - sinomenine; 4 - protopine; 5 - tetrahydropalmatine; 6 - corydaline. Detailed Description of the Embodiments
[0022] The present invention discloses a detection method for a traditional Chinese medicine composition comprising Sinomenii Caulis, Sophorae Flavescentis Radix, Anemarrhenae Rhizoma, Siegesbeckiae Herba, vinegar-processed Corydalis Rhizoma, Ajugae Herba, Ilicis Rotundae Cortex, Dioscoreae Hypoglaucae Rhizoma, and Acanthopanacis Senticosi Radix et Rhizoma seu Caulis. Sinomenii Caulis is the dried vine stem of Sinomenium acutum (Thunb.) Rehd. et Wils. and Sinomenium acutum (Thunb.) Rehd. et Wils. var. cinereum Rehd. et Wils. belonging to the Menispermaceae family. Sophorae Flavescentis Radix is the dried root of Sophora flavescens Ait. belonging to the Leguminosae family. Siegesbeckiae Herba is the dried aerial part of Siegesbeckia orientalis L., Siegesbeckia pubescens Makino or Siegesbeckia glabrescens Makino belonging to the Compositae family. Corydalis Rhizoma (Yanhusuo) is the dried tuber of Corydalis yanhusuo W. T. Wang belonging to the Papaveraceae family. Ajugae Herba is the dried whole herb of Ajuga decumbens Thunb. belonging to the Labiatae family. Ilicis Rotundae Cortex is the dried bark of Ilex rotunda Thunb. belonging to the Aquifoliaceae family. Dioscoreae Hypoglaucae Rhizoma is the dried rhizome of Dioscorea hypoglauca Palibin belonging to the Dioscoreaceae family. Acanthopanacis Senticosi Radix et Rhizoma seu Caulis is the dried root, rhizome or stem of Acanthopanax senticosus (Rupr. et Maxim.) Harms belonging to the Araliaceae family. Anemarrhenae Rhizoma is the dried rhizome of Anemarrhena asphodeloides Bge. belonging to the Liliaceae family.
[0023] Those skilled in the art can learn from the content herein and appropriately improve the process parameters for implementation. It should be particularly pointed out that all similar substitutions and modifications are obvious to those skilled in the art, and they are all deemed to be included in the present invention. The method and application of the present invention have been described through preferred embodiments, and relevant personnel can obviously make changes or appropriate modifications and combinations to the method and application described herein without departing from the content, spirit and scope of the present invention, so as to realize and apply the technology of the present invention.
[0024] Instruments and Test Materials
[0025] Mettler XP6 electronic analytical balance (Mettler Corporation);
[0026] Mettler Toledo AL204 electronic analytical balance (Mettler Corporation);
[0027] Mettler Toledo MS204 electronic analytical balance (Mettler Corporation);
[0028] Mettler Toledo MS-105DU electronic analytical balance (Mettler Corporation);
[0029] KQ5200DA CNC Ultrasonic Cleaner (Kunshan Ultrasonic Instrument Co., Ltd.);
[0030] HH Digital Display Thermostatic Water Bath (Changzhou Guoyu Instrument Manufacturing Co., Ltd.);
[0031] Mettler Toledo Seven Compact plus S120 pH meter (Mettler Corporation);
[0032] Milli-Q ultrapure water system (Milliber Corporation, USA).
[0033] High Performance Liquid Chromatography (HPLC):
[0034] Waters Arc high-performance liquid chromatograph, 2998PDA detector;
[0035] Agilent 1260 high performance liquid chromatograph with DAD ultraviolet detector;
[0036] Agilent 1200 high performance liquid chromatograph with MWD ultraviolet detector;
[0037] Sample: Traditional Chinese medicine composition preparation (Jiangsu Kangyuan Pharmaceutical Co., Ltd., batch number: 230501)
[0038] Reference standard: Matrine reference standard (China National Institutes for Food and Drug Control, batch number: 110805-202010, for content determination, purity 98.7%)
[0039] Sinomenine reference standard (China National Institutes for Food and Drug Control, batch number: 110774-201808, for content determination, purity 94.6%)
[0040] Sophoridine reference standard (China National Institutes for Food and Drug Control, batch number: 112052-202001, for content determination, purity 91.8%)
[0041] Original opioid reference standard (China National Institutes for Food and Drug Control, batch number: 110853-201805, for content determination, purity 99.6%)
[0042] Corydaline reference standard (China National Institutes for Food and Drug Control, batch number: 110726-202020, for content determination, purity 99.3%)
[0043] Corydaline A reference standard (Shanghai Hongyong Biotechnology Co., Ltd., batch number: 250152-202204, for content determination, purity 98%)
[0044] Reagents: Acetonitrile (Merida Corporation, USA, chromatographic grade); Potassium dihydrogen phosphate (Shanghai Maclean Company, chromatographic grade); Dipotassium hydrogen phosphate (Shanghai Maclean Company, chromatographic grade); all other reagents were of analytical grade.
[0045] Example 1
[0046] 1. Chromatographic conditions
[0047] 1.1 Selection of mobile phase
[0048] The elution system used was acetonitrile: [0.01 mol / L ammonium acetate methanol solution (adjusted to pH 8.1 with concentrated ammonia solution)] (3:2) - 0.01 mol / L ammonium acetate aqueous solution (adjusted to pH 8.1 with concentrated ammonia solution), acetonitrile - 0.033 mol / L potassium dihydrogen phosphate (0.05% triethylamine), and acetonitrile - phosphate buffer (pH 5.8). The elution system was used to detect matrine, sophoridine, sinomenine, protopine, corydaline B, and corydaline A. In the acetonitrile:[0.01mol / L ammonium acetate methanol solution (adjusted to pH 8.1 with concentrated ammonia solution)](3:2)-0.01mol / L ammonium acetate aqueous solution (adjusted to pH 8.1 with concentrated ammonia solution) and acetonitrile-0.033mol / L potassium dihydrogen phosphate (0.05% triethylamine) systems, the separation of the six target peaks in the sample was poor, and the peak shape of the reference standard was poor. In the acetonitrile-phosphate buffer (pH 5.8) system, matrine, sophoridine, sinomenine, protopine, corydaline, and corydaline A were detected, and the peak shapes and separation of each chromatographic peak were good, the retention time was stable, the preparation steps of the mobile phase solution were simple, the test solution (extraction method see 1.2.2) was stable and the target components were extracted to the required standard. Therefore, the acetonitrile-phosphate buffer (pH 5.8) system was selected as the elution system. Other chromatographic conditions: The HPLC flow rate was 0.9 mL / min, using a Phenomenex Gemini C18 column at 30℃, with an injection volume of 10 μL and a detection wavelength of 210 nm. Results are shown in Tables 1 and 2. Figure 1 .
[0049] Table 1 Gradient elution program 1
[0050]
[0051] Table 2 Gradient elution program 2
[0052]
[0053] By investigating different elution gradients, acetonitrile-phosphate buffer solution (pH 5.8) was selected as the mobile phase for gradient elution. The results of different elution programs are shown in Tables 3-5 and Appendix. Figure 2 .
[0054] Table 3 Gradient elution program 3
[0055]
[0056] Table 4 Gradient elution program 4
[0057]
[0058] Table 5 Gradient elution program 5
[0059]
[0060]
[0061] By investigating different elution gradients, under elution conditions 3 and 4, the resolution of the target peak in the sample was less than 1.5, failing to achieve baseline separation, and further optimization is needed. Under elution condition 5, the elution program performed best, with the resolution of matrine, sophoridine, sinomenine, protopine, corydaline, and corydaline A in the test sample chromatogram all greater than 1.5 with adjacent chromatographic peaks, achieving baseline separation, and the symmetry factor was 1.0. Therefore, acetonitrile-phosphate buffer (pH 5.8) gradient elution program 5 in Table 5 was selected, as detailed in Table 6.
[0062] Table 6. Separation results for different elution programs
[0063]
[0064] The final testing conditions were:
[0065] The HPLC chromatographic conditions used for detection employed gradient elution with the following program: 0–25 min, 5% A; 25–35 min, 5%–7% A; 35–50 min, 7%–15% A; 50–60 min, 15%–19% A; 60–80 min, 19%–20% A; 80–90 min, 20%–35% A; 90–115 min, 35% A; 115–120 min, 35%–44% A; 120–145 min, 44%–48% A. The HPLC flow rate was 0.9 mL / min, using a Phenomenex Gemini C18 column at 30 °C, with an injection volume of 10 μL and a detection wavelength of 210 nm.
[0066] 1.2 System Suitability Test
[0067] 1.2.1 Preparation of reference solution
[0068] Take appropriate amounts of matrine, sophoridine, sinomenine, protopine, corydaline B, and corydaline A reference standards, accurately weigh them, and add methanol to prepare a mixed reference solution containing 31.94 μg, 12.83 μg, 36.60 μg, 1.10 μg, 1.88 μg, and 1.68 μg of matrine, sophoridine, sinomenine, protopine, corydaline B, and corydaline A per mL, respectively.
[0069] 1.2.2 Preparation of the test solution
[0070] Accurately weigh approximately 0.3g of the product granules and place them in a stoppered conical flask. Add 30mL of purified water and sonicate for 15 minutes to dissolve (power 500W, frequency 40kHz). Then transfer the solution to a separatory funnel and extract five times with 30mL of chloroform each time. Combine the chloroform layers, evaporate to dryness, dissolve the residue in methanol, and dilute to a 10mL volumetric flask to obtain the final product.
[0071] 1.2.3 Measurement
[0072] Accurately pipette 10 μL of the reference solution and inject it into the liquid chromatograph. Repeat the injection 6 times and measure the peak area. Calculate the relative standard deviation of the peak area measurement. Accurately pipette 10 μL of the test solution and inject it into the high-performance liquid chromatograph. Detect the sample under the chromatographic conditions obtained above. Repeat the injection 6 times and calculate the peak area, theoretical plate number, resolution, and tailing factor of the analyte.
[0073] 1.2.4 Results
[0074] Under the above chromatographic conditions, the analyte in the test sample achieved baseline separation from adjacent chromatographic peaks, and the symmetry factor, relative standard deviation of chromatographic system repeatability, and theoretical plate number all met the analytical requirements, indicating that the system has good suitability.
[0075] 1.3 Investigation of the preparation method of the test solution
[0076] To optimize the preparation method of the test solution, the sample size, number of extractions, and extraction volume were investigated. The results are shown in Tables 7-9.
[0077] Table 7 Results of Sample Measurement Test
[0078]
[0079] Table 8 Results of the extraction number test
[0080]
[0081] Table 9 Results of the extraction dosage test
[0082]
[0083]
[0084] Based on the above test results, the preparation method of the test solution is determined as follows: Take about 0.3g of the product granules, accurately weigh them, place them in a stoppered conical flask, add 30mL of purified water, sonicate for 15 minutes to dissolve (power 500W, frequency 40kHz), then transfer to a separatory funnel, add chloroform to extract 5 times, 30mL each time, combine the chloroform layers, evaporate to dryness, dissolve the residue in methanol, and dilute to 10mL in a volumetric flask to obtain the test solution.
[0085] 1.4 Specificity Test
[0086] 1.4.1 Preparation of reference solution
[0087] Take appropriate amounts of matrine, sophoridine, sinomenine, protopine, corydaline B, and corydaline A reference standards, accurately weigh them, and add methanol to prepare a mixed reference solution containing 31.94 μg, 12.83 μg, 36.60 μg, 1.10 μg, 1.88 μg, and 1.68 μg of matrine, sophoridine, sinomenine, protopine, corydaline B, and corydaline A per mL, respectively.
[0088] 1.4.2 Preparation of test solution and negative test solution
[0089] Accurately weigh approximately 0.3 g of the granules and place them in a stoppered conical flask. Add 30 mL of purified water and sonicate for 15 minutes (500 W, 40 kHz) to dissolve. Then transfer the solution to a separatory funnel and extract five times with 30 mL of chloroform each time. Combine the chloroform layers, evaporate to dryness, dissolve the residue in methanol, and dilute to a 10 mL volumetric flask. Prepare negative test solutions for those lacking *Smilax glabra*, *Sophora flavescens*, and *Corydalis yanhusuo* using the same method.
[0090] 1.4.3 Measurement
[0091] Accurately pipette 10 μL each of the reference solution, test solution, and negative test solution into the high-performance liquid chromatograph (HPLC) for determination. The results showed that the negative test solution did not interfere with the determination of matrine, sophoridine, sinomenine, protopine, corydaline B, and corydaline A. (See attached figure for results.) Figure 3 .
[0092] 1.5 Examination of Linear Relationships
[0093] Accurately weigh appropriate amounts of matrine, sophoridine, sinomenine, protopine, corydaline, and corydaline A reference standards, and dissolve them in methanol to prepare solutions with concentrations of 0.7988 mg / mL for matrine, 0.3450 mg / mL for sophoridine, 0.9113 mg / mL for sinomenine, 0.0263 mg / mL for protopine, 0.045 mg / mL for corydaline, and 0.0413 mg / mL for corydaline A. These are the stock solutions of matrine, sophoridine, sinomenine, protopine, corydaline, and corydaline A reference standards. Take 0.1 mL, 0.2 mL, 0.4 mL, 1.0 mL, 2.0 mL, 4.0 mL, and 10.0 mL of this stock solution, and place them in 10 mL volumetric flasks. Add methanol to prepare a series of mixed reference standard solutions with standard curve concentrations 1–7. Accurately pipette 10 μL of each of the above solutions and inject them into the high-performance liquid chromatograph (HPLC). Record the peak area. Plot a standard curve with concentration (μg / mL) on the x-axis (X) and peak area on the y-axis (Y). Calculate the regression equations and correlation coefficients as follows: Matrine: Y = 19188.83X - 4777.92; r = 0.9999; Sophoridine: Y = 27119.81X + 5174.56; r = 0.9999; Sinapis: Y = 44623.79X - 24674.28; r = 1.0000; Protopine: Y = 87252.11X + 886.14; r = 0.9999; Corydaline: Y = 91 187.27X-1172.67; r=1.0000; Corydaline A: Y=86913.70X-966.72; r=1.0000; Results: Matrine and sinomenine showed good linearity in the concentration range of 1–6 (matrine 8.0–319.4 μg / mL, sinomenine 9.2–366.0 μg / mL); Sophoridine, protopine, corydaline B, and corydaline A showed good linearity in the concentration range of 1–7 (sophoridine 3.2–320.7 μg / mL, protopine 0.3–27.4 μg / mL, corydaline B 0.5–47.0 μg / mL, corydaline A 0.4–42.0 μg / mL), with r values greater than or equal to 0.9999. Results are shown in Tables 10–15.
[0094] Table 10 Results of linear relationship investigation of matrine
[0095]
[0096] Table 11 Results of the linear relationship investigation of sophoridine
[0097]
[0098]
[0099] Table 12 Results of linearity investigation of sinomenine
[0100]
[0101] Table 13 Results of the linear relationship investigation of protopine
[0102]
[0103] Table 14 Results of the linear relationship investigation of corydaline.
[0104]
[0105] Table 15 Results of the linear relationship investigation of corydaline.
[0106]
[0107] 1.6 Precision Test
[0108] Accurately pipette 10 μL each of the following reference solutions (low, medium, and high concentrations: matrine 7.98, 31.94, 319.37 μg / mL; sophoridine 3.21, 12.83, 320.75 μg / mL; sinomenine 9.15, 36.60, 366.03 μg / mL; protopine 0.27, 1.10, 27.44 μg / mL; corydaline 0.47, 1.88, 46.96 μg / mL; corydaline A 0.42, 1.68, 42.00 μg / mL) and the test solution. Inject 6 times repeatedly and calculate the injection precision. The results show that the instrument precision is good. The results are shown in Tables 16 and 17.
[0109] Table 16 Results of Precision Test for Reference Solution
[0110]
[0111]
[0112] Table 17 Results of Precision Test of Test Sample Solution
[0113]
[0114] 1.7 Stability Test
[0115] Take the same reference solution (matrine concentration: 79.84 μg / mL; sophoridine concentration: 32.07 μg / mL; sinomenine concentration: 91.51 μg / mL; protopine concentration: 2.74 μg / mL; corydaline concentration: 4.70 μg / mL; corydaline A concentration: 4.20 μg / mL) and the test solution, and inject 10 μL each time at 0h, 5h, 10h, 15h, 20h, 25h, 30h, 35h, 40h, and 45h for determination. The RSDs of the peak areas in the reference solutions were calculated to be 0.95% for matrine, 1.07% for sophoridine, 0.94% for sinomenine, 1.42% for protopine, 0.85% for corydaline B, and 0.74% for corydaline A; the RSDs of the peak areas in the test solutions were 0.64% for matrine, 0.60% for sophoridine, 0.55% for sinomenine, 0.79% for protopine, 0.38% for corydaline B, and 1.14% for corydaline A. The results showed that both the reference and test solutions were basically stable after 45 hours at room temperature. The results are shown in Tables 18 and 19.
[0116] Table 18 Results of stability tests on reference standards
[0117]
[0118] Table 19 Results of Stability Tests on Test Samples
[0119]
[0120] 1.8 Repeatability Test
[0121] Approximately 0.3 g of the herbal composition granules were used to prepare six test solutions. The contents were determined and calculated. The results showed that the matrine content was 1.83 mg / g (RSD 2.82%), sophoridine content was 0.78 mg / g (RSD 2.86%), sinomenine content was 2.30 mg / g (RSD 2.77%), protopine content was 0.07 mg / g (RSD 1.57%), corydaline content was 0.10 mg / g (RSD 2.70%), and corydaline A content was 0.07 mg / g (RSD 3.57%). The results indicate that the method has good repeatability. The results are shown in Table 20.
[0122] Table 20 Results of Repeatability Tests
[0123]
[0124] 1.9 Recovery Test
[0125] Take approximately 0.15 g of a sample with known content (matrine 1.83 mg / g, sophoridine 0.78 mg / g, sinomenine 2.30 mg / g, protopine 0.07 mg / g, corydaline 0.10 mg / g, corydaline A 0.07 mg / g), accurately weigh it, and take 9 parallel portions, grouping them into 3 portions each. Place them in a stoppered conical flask, and add appropriate amounts of the reference solutions for matrine, sophoridine, sinomenine, protopine, corydaline, and corydaline A to each group (matrine 319.37 mg / mL, sophoridine 128.30 mg / mL, sinomenine 366.03 mg / mL, protopine 10.98 mg / mL, corydaline 18.78 mg / mL, corydaline A 16.80 mg / mL). Then prepare the test solution according to the instructions. The average recoveries of matrine, styracin, styracin, and protopine were determined to be 94.32% (RSD = 3.24%), styracin 96.89% (RSD = 4.99%), styracin 97.83% (RSD = 4.95%), protopine 109.53% (RSD = 4.85%), corydaline 99.43% (RSD = 2.52%), and corydaline A 87.13% (RSD = 5.95%). The experimental results indicate that the method is accurate. The results are shown in Tables 21-26.
[0126] Table 21 Results of Matrine Recovery Test
[0127]
[0128] Table 22 Results of Sophoridine Recovery Rate Test
[0129]
[0130] Table 23 Results of the sinomenine recovery test
[0131]
[0132] Table 24 Results of the original opioid recovery test
[0133]
[0134]
[0135] Table 25 Results of Corydaline Recovery Test
[0136]
[0137] Table 26 Results of Corydaline Recovery Test
[0138]
[0139] Preparation example: Take 328g of *Sinomenium acutum*, 328g of *Sophora flavescens*, 492g of *Siegesbeckia orientalis*, 492g of *Corydalis yanhusuo* (processed with vinegar), 492g of *Ajuga decumbens*, 492g of *Illicium verum*, 328g of *Dioscorea hypoglauca*, 393.6g of *Acanthopanax senticosus*, and 328g of *Anemarrhena asphodeloides*. Add 10 times the amount of water and decoct twice, 1.5 hours each time. Concentrate under reduced pressure to an extract with a relative density of 1.08-1.12 (60℃-70℃). Spray dry, pulverize, add excipients such as dextrin, steviol glycosides, sucralose, aspartame, mannitol, and semathymidine, and granulate by dry method to obtain the final product.
[0140] The above are merely preferred embodiments of the present invention. It should be noted that those skilled in the art can make various improvements and modifications without departing from the principle of the present invention, and these improvements and modifications should also be considered within the scope of protection of the present invention.
Claims
1. A method for detecting the content of a traditional Chinese medicine composition, the traditional Chinese medicine composition comprising sinomenium acutum, sophora flavescens, anemarrhena asphodeloides, siegesbeckia orientalis, corydalis, smilax, rhizoma bupleuri, alisma orientalis, acanthopanax; characterized in that, The test solution of the traditional Chinese medicine composition was subjected to HPLC analysis. The chromatographic conditions for HPLC analysis included: A C18 column with a specification of 5 μm and a diameter of 4.6 × 250 mm was used; acetonitrile was used as mobile phase A, and phosphate buffer solution at pH 5.8 was used as mobile phase B. The elution program for the HPLC detection was as follows: 0–25 min, 5% A; 25–35 min, 5%–7% A; 35–50 min, 7%–15% A; 50–60 min, 15%–19% A; 60–80 min, 19%–20% A; 80–90 min, 20%–35% A; 90–115 min, 35% A; 115–120 min, 35%–44% A; 120–145 min, 44%–48% A. The preparation of the test solution includes taking this product and adding 30 mL of purified water, sonicating it for 15 minutes at a power of 500 W and a frequency of 40 kHz to dissolve it, then transferring it to a separatory funnel, adding chloroform to extract it 5 times, 30 mL each time, combining the chloroform layers, evaporating to dryness, dissolving the residue in methanol, and making up to 10 mL in a volumetric flask to obtain the test solution. The method also includes the detection of reference standards, which include matrine, sophoridine, sinomenine, protopine, corydaline B, and corydaline A standards.
2. The method according to claim 1, characterized in that, The chromatographic conditions include: a flow rate of 0.8–1.0 mL / min, a column temperature of 25–35 °C, and a detection wavelength of 208–212 nm.
3. The method according to claim 2, characterized in that, The chromatographic conditions include: a flow rate of 0.9 mL / min, a column temperature of 30°C, and a detection wavelength of 210 nm.
4. The method according to claim 1, characterized in that, The C18 column is selected from Phenomenex Gemini C18 column or Phenomenex Luna C18 column.
5. The method according to claim 4, characterized in that, The method for preparing the reference standards into solutions includes: taking matrine, sophoridine, sinomenine, protopine, corydaline B, and corydaline A standards, and adding methanol to prepare single or mixed standard solutions containing 7.98~319.37 mg of matrine, 3.21~320.75 mg of sophoridine, 9.15~366.03 mg of sinomenine, 0.27~27.44 mg of protopine, 0.47~46.96 mg of corydaline B, and 0.42~42.00 mg of corydaline A per 1 mL.
6. The method according to claim 1, characterized in that: The traditional Chinese medicine composition includes solid, liquid, or external preparations.
7. The method as described in claim 1, characterized in that, When the traditional Chinese medicine composition is in the form of granules, its preparation method includes: adding 10 times the amount of water to the following nine medicinal materials, namely, *Sinomenium acutum*, *Sophora flavescens*, *Siegesbeckia orientalis*, *Corydalis yanhusuo*, *Ajuga decumbens*, *Dioscorea hypoglauca*, *Acanthopanax senticosus*, and *Anemarrhena asphodeloides*, and decocting twice, each time for 1.5 hours, concentrating under reduced pressure to obtain an extract with a relative density of 1.08-1.12 at 60℃-70℃, spray drying, pulverizing, adding excipients, and dry granulating to obtain the final product.
Citation Information
Patent Citations
Method for analyzing near-infrared spectrum characteristic wave bands of phenylpropanoid, alkaloid or terpene compound based on near-infrared two-dimensional correlation spectrum
CN111693485A
Compound prescription of Chinese medicinal effective ingredients having anti-neovascularization synergetic effect
CN1965830A
